ResearchMoz

Singapore Medical Tourism Analysis and Forecast

Renub Research
Published Date » 2014-04-09
No. Of Pages » 74
 Singapore is one of the top medical tourist destinations in the world. With modern medical technology and highly trained doctors Singapore private hospitals offer exceptional health care services. Patients from all over the world visit to Singapore for treatment because Singapore has a team of high standard medical expertise along with many well known tourist attractions to explore. Singapore Tourism Board (STB) works closely with the private healthcare providers to strengthen and expand their reach and referral networks in key target markets. In addition, STB facilitates industry development capabilities to create and deliver value-added experiences so as to enhance service delivery for greater patient satisfaction. At the same time, STB continues to partner the private industry to...
Table of Content

1. Executive Summary

2. Singapore Medical Tourists Arrivals

3. Singapore Medical Tourism Market & Forecast

4. Singapore Medical Tourism – Country Wise Medical Tourists Arrivals, Spending & Forecast
4.1 United States – Medical Tourists Arrivals, Spending & Forecast
4.1.1 United States – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.1.2 United States – Medical Tourists Spending & Forecast (2004 - 2018) 
4.2 Canada – Medical Tourists Arrivals, Spending & Forecast
4.2.1 Canada – Medical Tourists Arrivals (2004 - 2008) 
4.2.2 Canada – Medical Tourists Spending (2004 - 2008) 
4.3 Indonesia – Medical Tourists Arrivals, Spending & Forecast
4.3.1 Indonesia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.3.2 Indonesia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.4 Malaysia – Medical Tourists Arrivals, Spending & Forecast
4.4.1 Malaysia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.4.2 Malaysia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.5 Philippines – Medical Tourists Arrivals, Spending & Forecast
4.5.1 Philippines – Medical Tourists Arrivals & Forecast (2005 - 2018) 
4.5.2 Philippines – Medical Tourists Spending & Forecast (2005 - 2018) 
4.6 Thailand – Medical Tourists Arrivals, Spending & Forecast
4.6.1 Thailand – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.6.2 Thailand – Medical Tourists Spending & Forecast (2004 - 2018) 
4.7 China – Medical Tourists Arrivals, Spending & Forecast 
4.7.1 China – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.7.2 China – Medical Tourists Spending & Forecast (2004 - 2018) 
4.8 Taiwan – Medical Tourists Arrivals, Spending & Forecast
4.8.1 Taiwan – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.8.2 Taiwan – Medical Tourists Spending & Forecast (2004 - 2018) 
4.9 Hong Kong – Medical Tourists Arrivals, Spending & Forecast
4.9.1 Hong Kong – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.9.2 Hong Kong – Medical Tourists Spending & Forecast (2006 - 2018) 
4.10 South Korea – Medical Tourists Arrivals, Spending
4.10.1 South Korea – Medical Tourists Arrivals (2004 & 2009) 
4.10.2 South Korea – Medical Tourists Spending (2004 & 2009) 
4.11 India – Medical Tourists Arrivals, Spending & Forecast
4.11.1 India – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.11.2 India – Medical Tourists Spending & Forecast (2004 - 2018) 
4.12 Netherlands – Medical Tourists Arrivals, Spending
4.12.1 Netherlands – Medical Tourists Arrivals (2006 & 2009) 
4.12.2 Netherlands – Medical Tourists Spending & Forecast (2006 & 2009) 
4.13 United Kingdom – Medical Tourists Arrivals, Spending & Forecast
4.13.1 United Kingdom – Medical Tourists Arrivals & Forecast (2005 - 2018) 
4.13.2 UK – Medical Tourists Spending & Forecast (2005 - 2018) 
4.14 Australia – Medical Tourists Arrivals, Spending & Forecast
4.14.1 Australia – Medical Tourists Arrivals & Forecast (2004 - 2018) 
4.14.2 Australia – Medical Tourists Spending & Forecast (2004 - 2018) 
4.15 Africa – Medical Tourists Arrivals, Spending & Forecast
4.15.1 Africa – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.15.2 Africa – Medical Tourists Spending & Forecast (2006 - 2018) 
4.16 Other Countries – Medical Tourists Arrivals, Spending & Forecast
4.16.1 Other Countries – Medical Tourists Arrivals & Forecast (2006 - 2018) 
4.16.2 Other Countries – Medical Tourists Spending & Forecast (2006 - 2018) 

List of Tables


List of Figures

Figure 2 1: Singapore – Medical Tourists Arrivals (Number), 2004 – 2013
Figure 2 2: Singapore – Forecast for Medical Tourists Arrivals (Number), 2014 – 2018
Figure 3 1: Singapore – Medical Tourism Market (Million US$), 2003 – 2013
Figure 3 2: Singapore – Forecast for Medical Tourism Market (Million US$), 2014 – 2018
Figure 4 1: Singapore – United States Medical Tourists Arrivals (Number), 2004 – 2013
Figure 4 2: Singapore – Forecast for United States Medical Tourists Arrivals (Number), 2014 – 2018
Figure 4 3: Singapore – United States Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 4: Singapore – Forecast for United States Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 5: Singapore – Canada Medical Tourist Arrivals (Number), 2004, 2007, 2008
Figure 4 6: Singapore – Canada Medical Tourism Spending (Million US$), 2004, 2007, 2008
Figure 4 7: Singapore – Indonesia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 8: Singapore – Forecast for Indonesia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 9: Singapore – Indonesia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 10: Singapore – Forecast for Indonesia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 11: Singapore – Malaysia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 12: Singapore – Forecast for Malaysia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 13: Singapore – Malaysia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 14: Singapore – Forecast for Malaysia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 15: Singapore – Philippines Medical Tourist Arrivals (Number), 2005 – 2013
Figure 4 16: Singapore – Forecast for Philippines Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 17: Singapore – Philippines Medical Tourism Spending (Million US$), 2005 – 2013
Figure 4 18: Singapore – Forecast for Philippines Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 19: Singapore – Thailand Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 20: Singapore – Forecast for Thailand Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 21: Singapore – Thailand Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 22: Singapore – Forecast for Thailand Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 23: Singapore – China Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 24: Singapore – Forecast for China Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 25: Singapore – China Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 26: Singapore – Forecast for China Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 27: Singapore – Taiwan Medical Tourist Arrivals (Number), 2004, 2006, 2009, 2010, 2013
Figure 4 28: Singapore – Forecast for Taiwan Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 29: Singapore – Taiwan Medical Tourism Spending (Million US$), 2004, 2006, 2009, 2010, 2013
Figure 4 30: Singapore – Forecast for Taiwan Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 31: Singapore – Hong Kong Medical Tourist Arrivals (Number), 2006, 2009, 2011, 2013
Figure 4 32: Singapore – Forecast for Hong Kong Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 33: Singapore – Hong Kong Medical Tourism Spending (Million US$), 2006, 2009, 2011, 2013
Figure 4 34: Singapore – Forecast for Hong Kong Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 35: Singapore – South Korea Medical Tourist Arrivals (Number), 2004, 2009
Figure 4 36: Singapore – South Korea Medical Tourism Spending (Million US$), 2004, 2009
Figure 4 37: Singapore – India Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 38: Singapore – Forecast for India Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 39: Singapore – India Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 40: Singapore – Forecast for India Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 41: Singapore – Netherlands Medical Tourist Arrivals (Number), 2006, 2009
Figure 4 42: Singapore – Netherlands Medical Tourism Spending (Million US$), 2006, 2009
Figure 4 43: Singapore – UK Medical Tourist Arrivals (Number), 2005 – 2009, 2013
Figure 4 44: Singapore – Forecast for UK Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 45: Singapore – UK Medical Tourism Spending (Million US$), 2005 – 2009, 2013
Figure 4 46: Singapore – Forecast for UK Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 47: Singapore – Australia Medical Tourist Arrivals (Number), 2004 – 2013
Figure 4 48: Singapore – Forecast for Australia Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 49: Singapore – Australia Medical Tourism Spending (Million US$), 2004 – 2013
Figure 4 50: Singapore – Forecast for Australia Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 51: Singapore – Africa Medical Tourist Arrivals (Number), 2006 – 2013
Figure 4 52: Singapore – Forecast for Africa Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 53: Singapore – Africa Medical Tourism Spending (Million US$), 2006 – 2013
Figure 4 54: Singapore – Forecast for Africa Medical Tourism Spending (Million US$), 2014 – 2018
Figure 4 55: Singapore – Other Countries Medical Tourist Arrivals (Number), 2006 – 2013
Figure 4 56: Singapore – Forecast for Other Countries Medical Tourist Arrivals (Number), 2014 – 2018
Figure 4 57: Singapore – Other Countries Medical Tourism Spending (Million US$), 2006 – 2013
Figure 4 58: Singapore – Forecast for Other Countries Medical Tourism Spending (Million US$), 2014 – 2018 

Upcoming Reports:

Large Cell Lymphoma Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Lymphoma is a major type of cancer. Lymphoma is a group of blood cancer, in which the blood cells, particularly, lymphocytes grow and divide very rapidly than normal rate. It is supported by enhanced duration of life of blood cells than that of a normal person. In most of the cases, lymphoma is present in the lymph nodes in the form of solid tumor. Lymphoma is a chronic and life-threatening disease and is a collective term for blood cancer; however, it is divided on various bases. One of the important class of lymphoma is large cell lymphoma. In this class, size of white blood...
Greece: vegetables market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the vegetables market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the vegetables market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Microencapsulation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Microencapsulation has been used across various industries since many years including agrochemical, pharmaceutical, food, paper industry and textiles. Microencapsulation is a process of coating small droplets or particles with a continuous film of polymeric material to produce small capsules known as microcapsules. There are many reasons behind encapsulation, some of them includes isolation from the surrounding, preventing evaporation of volatile substance, avoid unnecessary chemical attack on reactive materials and handling sticky material. In pharmaceutical industry, it has...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Philippines Falsifies Chinese Accusation on Disputed Spartly Islands
May 5, 2015  
Philippines authorities challenged China for accusations pertaining to construction on the disputed Spartly Islands.  The official Colomo Jr, responded to accusations by spokesperson of Foreign Ministry at China Hua Chunying that Philippines was building defense and civilian facilities such as ports, airports, and barracks on Spratly Islands that are claimed as Nansha Islands by...
Apple Hires New Contractor for Spaceship Campus
May 5, 2015  
Apple has aroused speculation about the completion of its ‘spaceship’ campus at Cupertino by 2016. This has happened on account of hiring a new general contractor for the construction of Apple Campus 2. The new contractor in picture is Rudolph & Sletten Inc. which is a Silicon Valley company. The company will carry out the build out of the interior of Apple Campus 2...
WuXi Starts Work on Largest Biologics Pant in China
May 5, 2015  
WuXi Biologics announced that it has commenced construction on the US$150 million production facility which will be part of its biologics unit. The company further announced, the facility will be the largest in size biologics production facility in China. It will be the largest plant in the world for the product of mammalian type cell cultures that will employ disposable...
Deputy Chief of Shanghai-Listed Bank under Investigation
May 5, 2015  
The Chinese finance industry has been hit by another corruption probe with the deputy chief of Hua Xia Bank being investigated for suspected disciplinary violations. The mid-sized Chinese bank announced that the antigraft authorities are investigating the charges against Wang Yaoting, one of its four vice presidents. The lender is listed on Shanghai Stock Exchange. In its filing, the bank...
Three Public Sector Banks Seek Exemption from Payment of Dividend
May 5, 2015  
Out of the 24 listed public sector banks in India, Bank of India, Allahabad bank, and Union Bank of India has sought exemption from the payment of dividend, owing to the high provisioning for the non-performing assets. Based on credit growth, market valuation, performance of the bank, and available capital, the government has recently approved of diluting the equity share holding of 52...